eHealth - Social Business in Health
7.4K views | +0 today
Follow
eHealth - Social Business in Health
ehealth, integrating care, health monitoring, on line communication, interaction and (mobile) technology to care for health better
Curated by rob halkes
Your new post is loading...
Scooped by rob halkes
Scoop.it!

Transforming Healthcare to Homecare - Ericsson ConsumerLab

Transforming Healthcare to Homecare - Ericsson ConsumerLab | eHealth - Social Business in Health | Scoop.it

New report (May 2017) from Ericsson
Healthcare transformation is taking root, moving away from hospitals and closer to the home.

 

Key findings

  • Healthcare becomes decentralized, moving from hospitals towards homes

Consumers are frustrated with inconveniences and doctor wait times; 39 percent of chronic patients prefer online consultations to face-to-face meetings. Close to two in three consumers say wearables that monitor and administer medication are important to better manage chronic ailments,leading to reduced visits to the doctor. More than half of cross-industry decision makers feel decentralizing healthcare to local centers will improve efficiency and address resource scarcity.

  • Patient data is centralized, turning hospitals into data centers

35 percent of consumers say that online access to a central repository of medical records will help them easily manage the quality and efficiency of their care; 45 percent of cross-industry experts consider the central repository as a breakthrough in healthcare provisioning. Access to patient data is considered important to improve healthcare. Doctors will become data scientists and data security will become paramount, as 46 percent of cross-industry decision makers already consider data security to be an issue.

  • Increasing dependence on wearables and remote treatments makes 5G essential to provide reliable and secure services

56 percent of consumers worry about their wearable health patches running out of battery; 42 percent of cross-industry decision makers expect devices connected to 5G networks to consume less power. 61 percent of consumers say remote robotic surgery is risky as it relies on the internet; and 35 percent of cross-industry decision makers expect 5G to provide reliable low-latency connections. 47 percent of telecom decision makers say that secure access to an online central repository is a key challenge and expect 5G to address this.

 

rob halkes's insight:

Mobile development in health care provision demands integrated care. We 've said it before: it urges all stakeholders to work together in a co-creative way - not just "doing things with each other" See http://bit.ly/co-creation-in-care ).

There's more to designing care than just settling on who does what. The art of doing business in care is a thing to learn. There are  three different kinds of care: See http://bit.ly/Integration-of-care

No comment yet.
Scooped by rob halkes
Scoop.it!

Patient engagement strategies in a digital environment

Patient engagement strategies in a digital environment | eHealth - Social Business in Health | Scoop.it

Patients are demanding care and solutions that are coordinated, convenient, customized, and accessible, and a number of nontraditional health companies are coming forward to address these emerging expectations, even as many large pharmaceutical companies focused on traditional markets have lagged behind.

Life sciences companies have a window of time to frame their patient engagement strategies  (Deloitte Review, 2016,18) for operating in the new, customer-centered, digital ecosystem— or risk the new players keeping them constrained within the traditional pharma model. [...]
Changes in technology and the health care ecosystem are increasing the patient’s role in decision making and reshaping their expectations from health care companies and is driven by several factors, including patients’ ability to change their own outcomes based on behavior, financial scrutiny due to cost-sharing models that push more costs onto the patient, the industry’s shift toward evaluating out- comes to determine value delivered to the patient, and the availability of technology solutions empowering patients with more information and the ability to play an active role in managing their well-being.
We’re also seeing a broad “consumerization” of health care products, expanding the ecosystem beyond the traditional players of providers, payers, big pharma, and health care data companies to include retail giants such as Nike, Apple Inc., and FitBit, as well as thousands of innovative mobile-application developers. As such, patients need to be thought of and engaged as traditional consumers when it comes to their use of health care products and services. [...]

The explosion of research in the area of patient engagement further speaks to the need for timeliness on the part of pharmaceutical companies implementing and executing engagement strategies, and nonprofit and public sector organizations can play a key role in making this happen. [...]

It makes sense that pharmaceutical companies would look to establish their brand for patient engagement services. Being able to deliver consistent service to patients and health care providers alike is paramount in building trust and loyalty. Conversely, and unsurprisingly, poor execution can drive the optics of a company’s brand in the wrong direction.

With regard to patient engagement, there is emerging support for moving away from a reactive approach, in which coordination between stakeholders, therapy, and care is limited or ad hoc, to a proactive model in which engagement tools and support bolster both patients and health care providers.
The bottom line is that there are any number of ways to structure patient services within an organization; so if the current structure isn’t effectively supporting and executing the patient engagement strategy and therapeutic outcomes, alternatives and precedents should be considered.[...]
No matter where patient services resides, a common platform across the organization and its vendors is becoming increasingly important, and is an effective way to leverage data as a strategic asset. [..]

Over the last three to five years, we have observed life sciences companies beginning to implement cloud-based platforms on which internal and external users can access the same platform, allowing the company to centrally control data access, ensure data quality, easily generate real-time reports, and quickly distribute system updates to all users. [...]
INSIGHT:

This report is great and pharma organizations should be aligning their organizations to increase patient engagement and think of new ways to reach and interact with patients.  This means striving to continually improve engagement through a patient centered approach at a time when a lot of people are going to have a hard time justifying the ROI.

 Read on here: http://bit.ly/1TSpvQD

rob halkes's insight:

Great review of Deloitte's study on patient engagement strategies!

Several aspects about its necessities are given, resp. discussed:

  • the issuess of patient services that need to be discussed;
  • the collaboration between stakeholders in the care system to upgrade the patient services;
  • the stages of development of the organization that one might follow to actually create and deliver these services.

However, pharma companies need to learn first how to engage themselves with patients and more specifically patient advocacy groups. Look here at PatientView about what patients' perceptions of the reputation of pharma companies is and for further information as to how you as a pharma company can increase your company's competency to align, service and work with patient groups: http://bit.ly/PatientView

 

No comment yet.
Scooped by rob halkes
Scoop.it!

Pharmacists may play active role in patient care

Pharmacists may play active role in patient care | eHealth - Social Business in Health | Scoop.it
Pharmacists would like pharma companies to provide them with online access to resources to help them support their patients
rob halkes's insight:

Last week I spent days in Moscow delivering a workshop in edetailing for a pharmaceutical company in Russia.

We became to talk how pharmacists do not always have specific drug intheir assortment. They just are not capable of selecting all items. There are several reasons to that, I came to know. One of them being the fact that a large part of patients need and/or can pay the prescribed drug themselves.

I guessed that if this is the case lots of added value to the patients can be realised through cooperation between physician and pharmacists. In my discussions I suggested that both could benefit and profit from the collaboration with patients. They can thus select a small range of drugs with which bot want to work. Pharma compnay's can help them with adding value to their proper drugs. And of course, the patients would be the champion of this closer cooperation. They do so in many cases in the Netherlands.

I guess that health care payer, insurance companies and state reimbursement institutions might want to experiment with personal medication budgets to patients, giving them the strength to buy and thus influencing an innovation in closer cooperation between physicians and pharamacists.

And, guess what: Today i was catching up with my twitter feeds and came across this blog from World of DTC Marketing ;-)

No comment yet.